Re: OT: adult antidepressants - reduced anxiety, altered inhibition, shift in evaluations of major purchases

[Guest guest]

>

> Back to the initial observation. How much of the " booming " economy

is

> due to individual anxiety levels artifically reduced by certain

> pharaceuticals? What proportion of credit card debt had Prozac and

> similar drugs as an etiologic factor?

>

Interesting thought . And maybe also to the thoughtless

choices many teens and young adults are making. Things like

shoplifting, careless sex, reckless driving, on and on. Maybe it's

the drugs or maybe it's the toxins that led to the use of the drugs.

And on the other hand from a personal note, my credit card debt is

certainly high but it is due to the cost of supplements, etc. to care

for and treat a vaccine injured child. Either way this it seems to

lead back to the same beginning triggers.

Michele

[Guest guest]

Credit card debt started to rise meteorically with the deregulation of

banking in the 80s. A missed payment means your rate goes skyrocketing past

what used to be illegal levels. (Ever wonder why certain businesses got

regulated in the first place? Duh.) You then become indebted without the

possibility of paying it down. The increase in consumer debt has paralleled

the decrease in the middle class. Many people who look middle class are

actually indentured servants of the credit card companies, with no hope of

economic recovery except to go bankrupt and start over again.

It would be interesting to know how close the ties of the pharmaceutical

companies are to the banking industry.

Liz

>

> Reply-To: csb-autism-rx

> Date: Fri, 27 Aug 2004 20:05:51 -0600

> To: " abmd " <abmd >

> Cc: csb autism group <csb-autism-rx >, a autism-mercury

> <autism-mercury >

> Subject: OT: adult antidepressants - reduced anxiety, altered

> inhibition, shift in evaluations of major purchases

>

>

> A friend in Estes Park offered a powerful connection.

>

> She has been taking antidepressants and, along with some of her friends,

> has come to realize that " reduced anxiety " seems to be an effect of the

> antidepressants and that the reduced anxiety alters how she makes major

> decisions. Specifically, her business may or may not have needed an

> $8,000 new device. In a small town, few business are cash cows, and hers

> isn't one of the few. Thus, contemplating an $8,000 expenditure ought to

> have induced hemming and hawing as the pros and cons were evauated prior

> to purchase. Instead, she rolled right along and spent the $8,000

> without her usual period of evalution and today was offering that

> antidepressants change how a person's intuition evaluates life options.

>

> Her point seems valid and may generalize. Recent articles have mentioned

> the ever increasing load of credit-card debt, and I can't help but

> wonder what percentage of that debt represents a family wherein one or

> both adults is a Prozac addict or is addicted to something similar.

> Among that subgroup of credit-card debtors, was the artificially

> enhanced daily mood the basis for developing a habit of reckless

> expenditures?

>

> The issue generalizes further now that a " we'll fix you via

> pharmaceuticals " paradigm rules the world. Yep, that seems a fair

> summary. As the former NEJM editor stated recently in the LATimes, among

> the Fortune 500, the net profits of the 10 biggest pharmcos exceeded the

> net profits of the other 490 corporations. Correspondingly, so many

> aspects of modern life in the US seem fraught with toxic perils and with

> nutritional perils. The " safe " levels of toxins allowed by " regulatory "

> agencies enforcing the Risk Management model cause " minor " insults and

> thereby boost pharm sales. Injected thimerosal serves a similar purpose.

> Junk food and overly processed food dominates most grocery shelves;

> diabetes, overweight, high blood pressure, etc, abound and help

> stimulate pharm sales. In sum, epidemics are blossoming amok, and

> they're not genetic epidemics, they're reflections of environmental

> factors and policies that encourage those environmental factors to cause

> physiological glitches that boost pharm sales. In contrast, some actual

> rebellions against the high church of " we'll fix you via

> pharmaceuticals " are occurring, as highlighted by governors and

> legislatures (regardless of party) who dare to say, We're going to help

> our citizens obtain Canadian drugs.

>

> Back to the initial observation. How much of the " booming " economy is

> due to individual anxiety levels artifically reduced by certain

> pharaceuticals? What proportion of credit card debt had Prozac and

> similar drugs as an etiologic factor?

>

>

>

>

>

>

>

>

> Many frequently asked questions and answers can be found at

> <http://forums.autism-rxguidebook.com>

>

[Guest guest]

Tryptophan was removed from the market just as Prozac was coming to

market. Both affect serotonin pathways. Tryptophan was much cheaper!

Yes, there were problems at a manufacturing plant re: tryptophan. The

solution wasn't Fix the production at that plant, instead the solution

was to remove a Prozac competitor from the market. I wonder how a graph

of antidepressant sales would parallel consumer credit card debt,

especially now that the nation is antidepressing and hormoning its

citizens by drugs leeching into water supplies.

son wrote:

>Credit card debt started to rise meteorically with the deregulation of

>banking in the 80s. A missed payment means your rate goes skyrocketing past

>what used to be illegal levels. (Ever wonder why certain businesses got

>regulated in the first place? Duh.) You then become indebted without the

>possibility of paying it down. The increase in consumer debt has paralleled

>the decrease in the middle class. Many people who look middle class are

>actually indentured servants of the credit card companies, with no hope of

>economic recovery except to go bankrupt and start over again.

>

>It would be interesting to know how close the ties of the pharmaceutical

>companies are to the banking industry.

>

>Liz

>

>

>

>

>